Cargando…

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

BACKGROUND: Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major clinical concern. However, little knowledge exists regarding suicide attempts in this patient group. This study presents the lifetime prevalence of suicide attempts and the associations between suicide attem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vold, Jørn Henrik, Løberg, Else-Marie, Aas, Christer F., Steier, Jan Alexander, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922793/ https://www.ncbi.nlm.nih.gov/pubmed/35291968 http://dx.doi.org/10.1186/s12888-022-03829-y

Ejemplares similares

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021)

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
por: Aas, Christer Frode, et al.
Publicado: (2021)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
por: Druckrey-Fiskaaen, Karl Trygve, et al.
Publicado: (2022)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway
por: Javadi Arjmand, Elaheh, et al.
Publicado: (2023)

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)
por: Fadnes, Lars T., et al.
Publicado: (2022)

Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences
por: Carlsen, Siv-Elin Leirvaag, et al.
Publicado: (2021)

Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study
por: Arjmand, Elaheh Javadi, et al.
Publicado: (2023)

Suicidal attempt by disinfectant solution ingestion in case of opioid dependence
por: Koulaei Nejad, Kiana, et al.
Publicado: (2022)

Chain of care for patients who have attempted suicide: a follow-up study from Bærum, Norway
por: Johannessen, Håkon A, et al.
Publicado: (2011)

Suicide and Attempted Suicide
por: Kessel, Neil
Publicado: (1966)

The association between psychological distress and alcohol consumption and physical activity: a population-based cohort study
por: Alpers, Silvia Eiken, et al.
Publicado: (2023)

Higher Suicide Intent in Patients Attempting Suicide With Violent Methods Versus Self-Poisoning: A Prospective Study From Norway
por: Persett, Per Sverre, et al.
Publicado: (2021)

Characteristics of Patients Who Complete Suicide and Suicide Attempts While Undergoing Treatment in Norway: Findings from Compensation Claims Records
por: Krvavac, Sanja, et al.
Publicado: (2023)

Perceived consequences and worries among youth in Norway during the COVID-19 pandemic lockdown
por: Lehmann, Stine, et al.
Publicado: (2021)

The association of prescription opioid use with suicide attempts: An analysis of statewide medical claims data
por: Luo, Chongliang, et al.
Publicado: (2022)

Collaboration between general hospitals and community health services in the care of suicide attempters in Norway: a longitudinal study
por: Mork, Erlend, et al.
Publicado: (2010)

ATTEMPTED SUICIDE IN LUDHIANA
por: Narang, R.L., et al.
Publicado: (2000)

Attempted suicide and pregnancy
por: Czeizel, Andrew E.
Publicado: (2011)

ATTEMPTED SUICIDES IN MADRAS
por: Ponnudurai, R., et al.
Publicado: (1986)

Suicide: Threatened and Attempted
por: Greenland, Cyril
Publicado: (1958)

Attempted Suicide with Adrenalin
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_53rldprm6r5coo3ea978s0vmf1